Human CRELD1 Protein (His Tag)
AVSD2,CIRRIN
- 100ug (NPP2051) Please inquiry
Catalog Number | P13411-H08H |
---|---|
Organism Species | Human |
Host | Human Cells |
Synonyms | AVSD2,CIRRIN |
Molecular Weight | The recombinant human CRELD1 consists of 344 amino acids and predicts a molecular mass of 37.4 KDa. It migrates as an approximately 51 KDa band in SDS-PAGE under reducing conditions. |
predicted N | Gln 30 |
SDS-PAGE | |
Purity | > 95 % as determined by SDS-PAGE |
Protein Construction | A DNA sequence encoding the human CRELD1 (NP_001070883.1) (Met1-Glu362) was expressed with a polyhistidine tag at the C-terminus. |
Bio-activity | |
Research Area | Cardiovascular |Heart |Cardiogenesis |Myocardial regeneration |
Formulation | Lyophilized from sterile PBS, pH 7.4 1. Normally 5 % - 8 % trehalose, mannitol and 0.01% Tween80 are added as protectants before lyophilization. Specific concentrations are included in the hardcopy of COA. |
Background | CRELD1 is a transmembrane glycoprotein. Epidermal growth factor(EGF)like domain exists in CRELD1. EGF-like repeats are a class of cysteine-rich domains that mediate interactions between proteins of diverse function. EGF domains are found in proteins that are either completely secreted or have transmembrane regions that tether the protein to the cell surface. CRELD1 contains a 333 amino acid acid (aa) extracellular domain (ECD), two tandem transmembrane segments, and a second ECD of 15 aa. Defects in CRELD1 may cause susceptibility to atrioventricular septal defect type 2 which results in a persistent common atrioventricular canal. |
Reference |